Literature DB >> 33451106

Enteric Viruses and Inflammatory Bowel Disease.

Georges Tarris1,2, Alexis de Rougemont2, Maëva Charkaoui3, Christophe Michiels3, Laurent Martin1, Gaël Belliot2.   

Abstract

Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), is a multifactorial disease in which dietary, genetic, immunological, and microbial factors are at play. The role of enteric viruses in IBD remains only partially explored. To date, epidemiological studies have not fully described the role of enteric viruses in inflammatory flare-ups, especially that of human noroviruses and rotaviruses, which are the main causative agents of viral gastroenteritis. Genome-wide association studies have demonstrated the association between IBD, polymorphisms of the FUT2 and FUT3 genes (which drive the synthesis of histo-blood group antigens), and ligands for norovirus and rotavirus in the intestine. The role of autophagy in defensin-deficient Paneth cells and the perturbations of cytokine secretion in T-helper 1 and T-helper 17 inflammatory pathways following enteric virus infections have been demonstrated as well. Enteric virus interactions with commensal bacteria could play a significant role in the modulation of enteric virus infections in IBD. Based on the currently incomplete knowledge of the complex phenomena underlying IBD pathogenesis, future studies using multi-sampling and data integration combined with new techniques such as human intestinal enteroids could help to decipher the role of enteric viruses in IBD.

Entities:  

Keywords:  Crohn’s disease; adenovirus; aichi virus; astrovirus; inflammatory bowel disease; norovirus; rotavirus; sapovirus; ulcerative colitis

Year:  2021        PMID: 33451106      PMCID: PMC7828589          DOI: 10.3390/v13010104

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  99 in total

1.  Cytomegalovirus complicating inflammatory bowel disease: a 10-year experience in a community-based, university-affiliated hospital.

Authors:  Raed Al-Zafiri; Adrian Gologan; Polymnia Galiatsatos; Andrew Szilagyi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-04

2.  Ectopic expression of blood type antigens in inflamed mucosa with higher incidence of FUT2 secretor status in colonic Crohn's disease.

Authors:  Jun Miyoshi; Tomoharu Yajima; Susumu Okamoto; Katsuyoshi Matsuoka; Nagamu Inoue; Tadakazu Hisamatsu; Katsuyoshi Shimamura; Atsushi Nakazawa; Takanori Kanai; Haruhiko Ogata; Yasushi Iwao; Makio Mukai; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2011-07-05       Impact factor: 7.527

3.  Enteropathogenic viruses: triggers for exacerbation in IBD? A prospective cohort study using real-time quantitative polymerase chain reaction.

Authors:  Gwen M C Masclee; John Penders; Marieke Pierik; Petra Wolffs; Daisy Jonkers
Journal:  Inflamm Bowel Dis       Date:  2013-01       Impact factor: 5.325

4.  Infection with murine norovirus 4 does not alter Helicobacter-induced inflammatory bowel disease in Il10(-/-) mice.

Authors:  Charlie C Hsu; Jisun Paik; Piper M Treuting; Audrey Seamons; Stacey M Meeker; Thea L Brabb; Lillian Maggio-Price
Journal:  Comp Med       Date:  2014-08       Impact factor: 0.982

5.  Enhanced GII.4 human norovirus infection in gnotobiotic pigs transplanted with a human gut microbiota.

Authors:  Shaohua Lei; Erica L Twitchell; Ashwin K Ramesh; Tammy Bui; Elizabeth Majette; Christine M Tin; Roger Avery; Gustavo Arango-Argoty; Liqing Zhang; Sylvia Becker-Dreps; M Andrea Azcarate-Peril; Xi Jiang; Lijuan Yuan
Journal:  J Gen Virol       Date:  2019-11       Impact factor: 3.891

6.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

7.  Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus.

Authors:  Christopher M Robinson; Palmy R Jesudhasan; Julie K Pfeiffer
Journal:  Cell Host Microbe       Date:  2014-01-15       Impact factor: 21.023

8.  Enteric Infections Are Common in Patients with Flares of Inflammatory Bowel Disease.

Authors:  Jordan E Axelrad; Andrew Joelson; Peter H R Green; Garrett Lawlor; Simon Lichtiger; Ken Cadwell; Benjamin Lebwohl
Journal:  Am J Gastroenterol       Date:  2018-08-03       Impact factor: 10.864

9.  The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-10-21

10.  Enterobacter cloacae inhibits human norovirus infectivity in gnotobiotic pigs.

Authors:  Shaohua Lei; Helen Samuel; Erica Twitchell; Tammy Bui; Ashwin Ramesh; Ke Wen; Mariah Weiss; Guohua Li; Xingdong Yang; Xi Jiang; Lijuan Yuan
Journal:  Sci Rep       Date:  2016-04-26       Impact factor: 4.379

View more
  6 in total

Review 1.  FUT2 gene as a genetic susceptible marker of infectious diseases: A Review.

Authors:  Paramvir Kaur; Madhu Gupta; Vivek Sagar
Journal:  Int J Mol Epidemiol Genet       Date:  2022-06-15

Review 2.  Epidemiology, Clinical Features, and Unusual Complications of Norovirus Infection in Taiwan: What We Know after Rotavirus Vaccines.

Authors:  Meng-Che Lu; Sheng-Chieh Lin; Yi-Hsiang Hsu; Shih-Yen Chen
Journal:  Pathogens       Date:  2022-04-09

3.  Mesenchymal stem cells-derived extracellular vesicles containing miR-378a-3p inhibit the occurrence of inflammatory bowel disease by targeting GATA2.

Authors:  Ping Li; Hai-Yan Zhang; Jian-Zhen Gao; Wen-Qiang Du; Dong Tang; Wei Wang; Liu-Hua Wang
Journal:  J Cell Mol Med       Date:  2022-05-17       Impact factor: 5.295

Review 4.  Norovirus: Facts and Reflections from Past, Present, and Future.

Authors:  Yalda Lucero; David O Matson; Shai Ashkenazi; Sergio George; Miguel O'Ryan
Journal:  Viruses       Date:  2021-11-30       Impact factor: 5.048

5.  Network pharmacology analysis and experimental study strategy reveals the potential mechanism of puerarin against rotavirus.

Authors:  Ting Chen; Yujie Lin; Zhiqun Cao; Ye Xue; Wei Wang; Xiaoyan Wang
Journal:  Ann Transl Med       Date:  2022-01

Review 6.  Fucosyltransferase 2: A Genetic Risk Factor for Intestinal Diseases.

Authors:  Mingyang Hu; Xiyun Zhang; Jinze Li; Luotong Chen; Xiaolin He; Tingting Sui
Journal:  Front Microbiol       Date:  2022-07-18       Impact factor: 6.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.